Craneware (LSE:CRW)

Craneware is a specialist in software for healthcare billing, auditing, 'Chargemaster' management and medicare compliance.

Related Articles

• Friday, 28th June, 2019 | Roland Head

  Are Costain and Craneware falling knives to catch after 30%+ crashes?

  Roland Head gives his view on today's profit warnings from Cranweware plc (LON: CRW) and Costain Group plc (LON: COST). Read More »

• Thursday, 10th January, 2019 | Robert Faulkner

  One Brexit-proof stock that I’d buy today

  Read this to find out why I think this AIM stock could deliver impressive returns. Read More »

• Friday, 21st December, 2018 | Roland Head

  The Boohoo share price has fallen 20% in 2018. Will it bounce back in 2019?

  Boohoo Group plc (LON:BOO) shares have fallen on fears of a retail slowdown. Roland Head asks if investors should be buying. Read More »

• Tuesday, 4th September, 2018 | Paul Summers

  This top growth stock has turned £5,000 into over £27,500 in just 5 years

  Can this multi-bagging stock continue to perform? Paul Summers wouldn't bet against it. Read More »

• Wednesday, 14th March, 2018 | Paul Summers

  2 high-flying growth stocks I’d consider buying for the long term

  Expensive they may be but these growth stocks could be great buys for the long term, thinks Paul Summers. Read More »

• Tuesday, 6th March, 2018 | Ian Pierce

  Why I’d ditch plummeting Boohoo.com plc for this fast-rising growth star

  Even after dropping over 25% in the past half-year, Boohoo.com plc (LON: BOO) still looks expensive compared to this under-the-radar growth star. Read More »

• Tuesday, 13th February, 2018 | Alan Oscroft

  A soaring growth stock I’d buy ahead of Fevertree Drinks plc

  Fevertree Drinks plc (LON: FEVR) shares have soared, but is this growth stock set to overtake them? Read More »

• Monday, 8th January, 2018 | Peter Stephens

  2 promising small-cap stocks that could be millionaire-makers in 2018

  These two shares could help you to generate high returns. Read More »

• Wednesday, 8th November, 2017 | Paul Summers

  These ‘secret’ growth stocks could still make you stunningly rich

  They may be expensive but Paul Summers thinks there could be more upside ahead for investors in these small-cap growth stocks. Read More »

• Tuesday, 31st October, 2017 | Peter Stephens

  Why GlaxoSmithKline plc is a growth bargain I’d buy and hold for 25 years

  GlaxoSmithKline plc (LON: GSK) could be one of the best investment opportunities in the FTSE 100. Read More »